Search results :

Sotalol

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: C07AA07

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Fatigue 2% - 20% 8.5% x x x x x x x x x x x x x x x x
Dizziness 1% - 20% 12.4% x x x x x x x x x x x x x x x x
Dyspnoea postmarketing, 2% - 21% 7.4% x x x x x x x x x x x x x x x x
Palpitations postmarketing, 1% - 14% x x x x x x x x x x x x
Bradycardia postmarketing, 2% - 16% 2.5% x x x x x x x x x x x x x x x x
Lightheadedness 1% - 12% x x x x x x x x x x x x
Nausea 1% - 10% 5.3% x x x x x x x x x x x x x x x
Vomiting 1% - 10% 5.3% x x x x x x x x x x x x x x x
Asthenia 1% - 13% 3.2% x x x x x x x x x x x x x x x x
Hyperhidrosis 4.9% - 5.2% 3.2% x x x x x
Cardiac pain 2.5% - 4.6% 4.6% x x x x x
Chest pain postmarketing, 1% - 16% 1.4% x x x x x x x x x x x x x x x x
Headache 1% - 11.5% 5.3% x x x x x x x x x x x x x x x x
Cough 2.5% - 3.3% 2.5% x x x x x
Pain 2.5% - 4.1% 2.5% - 2.8% x x x x x
Diarrhoea 1% - 7% 2.1% x x x x x x x x x x x x x x x x
Dyspepsia 1% - 6% 1.8% x x x x x x x x x x x x x x x x
Oedema postmarketing, 1% - 8% x x x x x x x x x x x x
Rash 1% - 5% x x x x x x x x x x x x
Hypotension postmarketing, 2% - 6% x x x x x x x x x x x x
Pain in extremity 1% - 7% x x x x x x x x x
Proarrhythmia postmarketing, 1% - 7% x x x x x x x x x x x x x x x x
Upper respiratory tract infection 2.6% - 3.3% 1.1% x x x x x
Insomnia 2.6% - 4.1% 1.1% x x x x x
Abdominal pain 1% - 3% x x x x x x x x x x x x
Angina pectoris 1.6% - 2% 1.1% x x x x x
Anxiety 1% - 4% x x x x x x x x x x x x
Appetite disorder 1% - 3% x x x x x x x x
Back pain 1% - 3% x x x x x x x x x
Cardiovascular disorder 1% - 3% x x x x x
Infection 1% - 4% x x x x x x x x x
Depression 1% - 4% x x x x
Body temperature increased postmarketing, 1% - 4% 0.7% x x x x x x x x x x x x x x x x
Cardiac failure postmarketing, 1% - 5% x x x x x x x x x x x x
Heartburn 2% - 2.5% 1.8% x x x x x
Influenza 0.8% - 2% 0.4% x x x x x
Paraesthesia 1% - 4% x x x x x x x x x x x
Syncope postmarketing, 1% - 5% x x x x x x x x x x x x
Decreased appetite 1.6% - 2% 0.4% x x x x x
Consciousness abnormal 1% - 4% x x x x x x
Pain localised 1% - 3% x x x x x x x x x
Electrocardiogram abnormal 1% - 7% x x x x x x x x x
Presyncope postmarketing, 1% - 4% x x x x x x x x x x x x
Torsade de pointes 1% - 4.1% x x x x x x x x x x x x x x x
Asthma 1% - 2% x x x x x x x x x
Flatulence 1% - 2% x x x x x x x x x x x x
Haemorrhage 1% - 2% x x x x x x x x x
Hypertension 1% - 2% x x x x x x x x x
Vasodilation 1% - 3% x x x x x x x x x
Urogenital disorder 0% - 3% x x x x x x
Peripheral vascular disorder 1% - 3% x x x x x
Mood swings 1% - 3% x x x x x x x x x x x x x x x
Sexual dysfunction 1% - 3% x x x x x x x x x
Distention 0.7% - 2.5% 0.4% x x x x x
Tracheobronchitis 0.7% - 3.3% 0.7% x x x x x
Sustained ventricular tachycardia 0.3% - 1.2% x x x
Cerebrovascular accident 1% x x x x x x x
Alopecia postmarketing x x x x x x x x x x x
Eosinophilia postmarketing x x x x x x x x x x x x x
Hyperlipidaemia postmarketing x x x x x x x x x x x x x
Leukopenia postmarketing x x x x x x x x x x x x x
Pruritus postmarketing x x x x x x x x x x x x x x x x
Pulmonary oedema postmarketing x x x x x x x x x x x x x
Thrombocytopenia postmarketing x x x x x x x x x x x x x
Vertigo postmarketing x x x x x x x x x x x x x x x x
Photosensitivity reaction postmarketing x x x x x x x x x x x x x
Myalgia postmarketing x x x x x x x x x x x x x
Coordination abnormal postmarketing x x x x x x x x x x x x x
Paralysis postmarketing x x x x x x x x x x x x x
Agranulocytosis x x
Atrioventricular block x x x x x x x x x x x
Bronchospasm x x x
Catatonia x x
Sudden death x
Drowsiness x x x
Dysgeusia x x x
Hyperglycaemia x x x x x x x x x x x x x
Hyperinsulinism x x x x x x x x x x x x x
Laryngospasm x x
Lethargy x x x
Cramp muscle x x x
Myocardial infarction x x x
Peyronie's disease x x
Neuropathy peripheral x x x x x x x x x x x x x
Purpura x x
Retroperitoneal fibrosis x x x
Cardiogenic shock x x x
Sleep disturbance x x x
Angiopathy x x
Ventricular fibrillation x x x
Ventricular tachycardia x x x x
Tachyarrhythmia x x
Atrioventricular block first degree x x
Photophobia x x x
Ventricular extrasystoles x x x
Electrocardiogram QT prolonged x x x
Arterial thrombosis x x
Colitis ischaemic x x
Disorientation x x
Ache x x
Eye irritation x x x
Throat sore x x
Peripheral coldness x x x
Atrophy x x x
Vision blurred x x x
Multifocal ventricular tachycardia x
Respiratory distress x x
Visual disturbance x x x
Short-term memory loss x x
Non-sustained ventricular tachycardia x x x
Alopecia reversible x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Sotalol hydrochloride / Sotacor, Tablet

Side effects:51
Source:Medsafe

COMPOSITION / SOTALOL

Side effects:53
Source:medicines.org.au

COMPOSITION / SOTALOL

Side effects:53
Source:medicines.org.au

SOTALOL HYDROCHLORIDE / BETAPACE AF

Side effects:41
Source:FDA

SOTALOL

Side effects:42
Source:FDA Structured Product Label

sotalol

Side effects:43
Source:FDA Structured Product Label

SOTALOL

Side effects:43
Source:FDA Structured Product Label

SOTALOL HYDROCHLORIDE / PHL-SOTALOL

Side effects:66
Source:Health Canada

SOTALOL HYDROCHLORIDE / RATIO-SOTALOL

Side effects:67
Source:Health Canada

Sotalol

Side effects:51
Source:FDA Structured Product Label

sotalol

Side effects:59
Source:FDA Structured Product Label

SOTALOL

Side effects:59
Source:FDA Structured Product Label

SOTALOL

Side effects:59
Source:FDA Structured Product Label

SOTALOL

Side effects:59
Source:FDA Structured Product Label

SOTALOL

Side effects:60
Source:FDA Structured Product Label

Sotalol

Side effects:72
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label